Obesity: from epidemiology to treatment Entwicklung der Adipositas und Epidemiology, definition and des Diabetes in Europa diagnosis of obesities

Similar documents
2017 Employee Wellness Health Assessment Report

Underage drinking in Europe

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

Director, Employee Health & Productivity. Coordinator, Employee Health & Productivity

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight

Client Report Screening Program Results For: Missouri Western State University October 28, 2013

David Wright, MD Speaking of Women s Health Shawnee Mission Medical Center October 4, 2013

An update on the obesity epidemics in CKD and in ESRD. Does it really matter?

2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE

3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.

Guidelines on cardiovascular risk assessment and management

DECLARATION OF CONFLICT OF INTEREST. None

European Dietetic Action Plan EuDAP ( )

Rick Fox M.A Health and Wellness Specialist

Diagnostic Test of Fat Location Indices and BMI for Detecting Markers of Metabolic Syndrome in Children

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Models of preventive care in clinical practice to achieve 25 by 25

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah

COMMISSION OF THE EUROPEAN COMMUNITIES

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Risk Monitor How-to guide

Brussels, Belgium. 8 December 2010

European guidelines on obesity. From a dietetic perspective Ellen Govers, RD, ESDN Obesity EFAD Amsterdam, October

Media centre Obesity and overweight

EuroPRevent Risk assessment models: what is to come? Risk Assessment Models: Applications in Clinical Practice

OBESITY IN PRIMARY CARE

LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME

European Status report on Alcohol and Health

Supplementary Online Content

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

The health economic landscape of cancer in Europe

Association between arterial stiffness and cardiovascular risk factors in a pediatric population

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Smokefree Policies in Europe: Are we there yet?

Rheumatoid Arthritis Disease Burden and Access to Treatment

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.

Where we stand in EFORT

Weight management. Understanding the causes, prevention, assessment and management of obesity

Obesity Causes Complications and Dietary Weight Loss Strategy

SOUTH AFRICAN DECLARATION ON THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES

European status report on alcohol and health Leadership, awareness and commitment

BDS, MSc, MSPH, MHPE, FFPH, ScD. Associate Prof. of Epidemiology and Biostatistics. Associate Prof. Medical Education

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

Testosterone therapy (TTh) prevents progression from prediabetes to type 2 diabetes (T2DM) in hypogonadal: 9-year data from a registry study

SOUTH AFRICAN DECLARATION ON THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES

The role of physical activity in the prevention and management of hypertension and obesity

OBESITY: The Growing Epidemic and its Medical Impact

2013 ACC/AHA Guidelines on the Assessment of Atherosclerotic Cardiovascular Risk: Overview and Commentary

CHRODIS Kick-off. Communication and Dissemination. Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Joint Programming in Neurodegenerative Disease Research (JPND)

2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications

The National Diabetes Prevention Program in Washington State March 2012

The Metabolic Syndrome: Is It A Valid Concept? YES

The State of Play of Diabetes Indicators

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Referral to a commercial weight management programme enhances weight loss achieved in primary care

EU food policy: public health beyond the internal market

Why Screen at 23? What can YOU do?

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Procedures for taking physical measurements

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

Obesity Policy in Europe: the need for Education, Treatment and Care

PREVALENCE OF METABOLİC SYNDROME İN CHİLDREN AND ADOLESCENTS

The challenge of obesity in the WHO European Region

National Strategy. for Control and Prevention of Non - communicable Diseases in Kingdom of Bahrain

Health and. Consumers

Alcohol-related harm in Europe and the WHO policy response

EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium

Alcohol Prevention Day

Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults

programme. The DE-PLAN follow up.

Deliverable. Grant Agreement number: Open Access Policy Alignment STrategies for European Union Research. FP7 CAPACITIES Science in Society

Faculty of Health Sciences Outcomes of campaigns for Palestine refugees with diabetes mellitus attending UNRWA health centers

1Health Improvement Card. User guide for health professionals

Metabolic Factors Frequency of Chocolate Consumption and Body Mass Index

Overview of drug-induced deaths in Europe - What does the data tell us?

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Cardiovascular Risk Assessment and Management Making a Difference

Prof. Renata Cífková, MD, CSc.

Metabolic Syndrome: What s in a name?

Implications of The LookAHEAD Trial: Is Weight Loss Beneficial for Patients with Diabetes?

Current dietary habits in Europe far from plant based eating

WIN QUARTERLY UTILIZATION REPORT 7/1/2010 TO 12/31/2010. EXPERTISE PARTNERSHIP V A L U E April 20, 2011

The burden caused by alcohol

Healthy Weight for Ireland

Assessing food environments to monitor policy implementation. Boyd Swinburn Professor of Population Nutrition & Global Health University of Auckland

Prevention in Europe

CNAPA Meeting Luxembourg September 2016

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Role of UN Agencies in Achieving the Sustainable Development Goals (SDG 3.4)

Cardiovascular Disease After Spinal Cord Injury: Achieving Best Practice. Suzanne Groah, MD, MSPH Walter Reed Army Medical Center February 12, 2010

Presenter: Lurline Less April 2018

Transcription:

Obesity: from epidemiology to treatment Entwicklung der Adipositas und Epidemiology, definition and des Diabetes in Europa diagnosis of obesities Hermann Toplak, Präsident ÖDG &EASO Hermann Toplak, President EASO Medizinische Universität Graz Medical University of Graz, Austria

Genes in a new environment

Our modern lifestyle with the old genes...

Prevalence of Obesity and Diabetes (in US Adults 1991 & 2001) Obesity Diabetes Mokdad AH et al. JAMA 2003;289:76 79.

http://www.iotf.org/database/trendseuropeanadultsthroughtimev3.htm

Share of obese persons in the EU, by education level, 2014 (%) 20 19.9 16.0 15 11.5 10 5 0 Low education level Medium education level High education level Geographical information The European Union (EU) includes Belgium, Bulgaria, the Czech Republic, Denmark, Germany, Estonia, Ireland, Greece,

2015 Communications: Milan Declaration

Milan Declaration calls to action: To address this situation, obesity should become a top priority, with increased commitment for concerted, coordinated and specific actions. A comprehensive, sustainable and pro-active strategy to deal with the challenges posed by the obesity epidemic is urgently needed. Encouraging the development and implementation of programmes for prevention, early diagnosis and treatment is mandatory. It is clearly imperative that obesity, as a disease and as a gateway to NCDs, is targeted as an area for immediate action and priority for research, innovation and action. In 1999 EASO issued a Milan Declaration in which we called for recognition, support and national action in this field. In the intervening years great progress has been made but more needs to be done and we must act now.

Milan Declaration Statement I It is clear that weight management must now play a major role in reducing morbidity and mortality of populations in Europe and world-wide. EASO resolves to provide leadership, guidance and support to governments, as part of its mission of facilitating and engaging in actions that reduce the burden of unhealthy excess weight in Europe through prevention and management, but a wider effort is needed. EASO therefore calls on governments, health agencies and all relevant stakeholders to: Recognise that individuals and communities who are obese require understanding, respect and support.

Milan Declaration Statement III Prioritise obesity as a national health action, by developing, supporting and implementing national strategies for action on obesity. These strategies must prioritise medical education (undergraduate and HCPs) and public information campaigns. Prioritise the identification of critical unmet needs in obesity research, clinical care, education and training and other areas that have yet to be adequately addressed. Support national and European research that will inform and develop new and effective prevention and management strategies, thus delivering real societal benefit.

BMI and BMI are not equal... Waist circumference is adding information 189 cm, 93 kg = BMI 26 190 cm, 94 kg = BMI 26 Waist circumference Testosteron > < Waist circumference Testosteron Title time and place of presentation Page #

All cause mortality in Denmark Unadjusted --- Adjusted Bigaard et al. Obesity 2003

Body fat (%) Body fat (%) Correlation between BMI & body fat percentage r = 0.78 P < 0.00001 n = 1,915 r = 0.87 P < 0.00001 n = 4,208 BMI (kg/m 2 ) Men Women Gómez-Ambrosi et al. Int J Obesity 2012 BMI (kg/m 2 )

Lean BMI-based classification Overweight Obese >18.0-24.9 kg/m 2 >25.0-29.9 kg/m 2 >30.0 kg/m 2 Gómez-Ambrosi et al. Int J Obesity 2012 % Body fat-based classification 0.2% 1.0% 29% 80%

Body fat (%) Correlation between BMI & body fat percentage Body fat (%) NOOB: Non-Obese-BMI/Obese BF% OBOB: Obese-BMI/Obese BF% MEN WOMEN NOOB NOOB n = 371 OBOB n = 1208 n = 445 OBOB n = 371 n = 96 r = 0.78 P < 0.00001 n = 1,915 n = 560 r = 0.84 P < 0.00001 n = 4,208 BMI (kg/m 2 ) BMI (kg/m 2 ) BMI BF% NOOB 27.8 31.5 OBOB 32.8 kg/m 2 31.0 % BMI BF% NOOB 26.8 40.9 OBOB 32.8 kg/m 2 41.4 % Gómez-Ambrosi et al. Int J Obes 2012

Body fat (%) Body fat (%) MEN WOMEN n = 371 n = 1208 n = 445 n = 371 n = 96 r = 0.78 P < 0.00001 n = 1,915 n = 560 r = 0.84 P < 0.00001 n = 4,208 BMI (kg/m 2 ) Non-obese subjects by the BMI criterion but obese by BF% exhibit: Gómez-Ambrosi et al. Int J Obesity 2012 BMI (kg/m 2 ) Waist circumference Blood pressure Glucose, insulin, triglycerides, total cholesterol and LDL-chol. levels Fibrinogen and CRP concentrations HDL-cholesterol levels

Increased risk in Non-Obese BMI-high BF NOOB: Non-Obese-BMI/Obese BF% OBOB: Obese-BMI/Obese BF% 500 400 Fibrinogen Fibrinogen * * 500 400 Fibrinogen Fibrinogen mg/dl 300 200 mg/dl 300 200 100 100 logcrp (mg/l) 0 1.6 1.2 0.8 0.4 0.0-0.4 Lean NOOB OBOB C-reactive protein C-reactive protein Lean NOOB OBOB * * * * 1.2 logcrp (mg/l) 0 1.6 0.8 0.4 0.0-0.4 C-reactive protein C-reactive protein -0.8 Lean NOOB OBOB *P<0.05 vs Lean; P<0.05 vs NOOB -0.8 Lean NOOB OBOB Gómez-Ambrosi et al. Int J Obes 2012

kg/m 2 Men 30 25 20 15 BMI Body fat % 50 P = 0.091 P = 0.008 P = 0.139 40 30 20 10 cm 110 100 90 80 70 Waist 10 NG PreDiab/T2D 0 NG PreDiab/T2D 60 NG PreDiab/T2D Women 30 BMI Body fat 60 P = 0.216 P < 0.0001 P < 0. 0001 110 100 Waist kg/m 2 20 10 % 40 20 cm 90 80 70 60 0 NG PreDiab/T2D Gómez-Ambrosi et al. Obesity 2011 0 NG PreDiab/T2D 50 NG PreDiab/T2D

BMI, Body fat, Fat free mass and mortality Bigaard et al. Obesity Research 2004

Commentary to NCD 11 will be published 2017 When speaking about a disease seems to be useful using BMI cutoffs above 30 kg/m 2 otherwise we declare half of the population as diseased It will be important to have obesity as a single entity, not in the nutrition part, as it is also lack of exercise and others So a main category obesity following nutrition will be necessary in ICD (with subcategories) Dimension Etiology (multifactorial or attributable to a major cause like iatrogenic, endocrinologically induced, tumor-induced, genetically determined, other ) Dimension Extent (Classes I-VI: 30, 35, 40, 45, 50 and 55) Manuscript by EASO expected within the next months in Obesity Facts

Thank you for your kind attention!